hyobac app 2 vet. injektionsvæske, emulsion
salfarm danmark a/s - actinobacillus pleuropneumoniae toxoid apx ii, stamme wslb 3012, actinobacillus pleuropneumoniae toxoid apx iii, stamme wslb 3012, actinobacillus pleuropneumoniae, serovar 2, stamme wslb 3012 - injektionsvæske, emulsion - svin
osvaren 435+235 mg filmovertrukne tabletter
orifarm a/s - calciumacetat, magnesiumcarbonat, tungt - filmovertrukne tabletter - 435+235 mg
stellamune mycoplasma vet. 6000 ru/dosis injektionsvæske, emulsion
elanco gmbh - mycoplasma hyopneumoniae, stamme p-5722-3 (inaktiveret) - injektionsvæske, emulsion - 6000 ru/dosis - svin
stellamune one vet. 4,5-5,2 log10/dosis injektionsvæske, emulsion
elanco gmbh - mycoplasma hyopneumoniae, stamme nl1042 (inaktiveret) - injektionsvæske, emulsion - 4,5-5,2 log10/dosis - svin
milbeknock (reg.nr. 735-2) flydende middel
sumi agro europe limited, zweigniederlassung deutschland - milbemectin - flydende middel - 9,3 g/l milbemectin
finomel infusionsvæske, emulsion
baxter a/s - alanin, arginin, calciumchloriddihydrat, fiskeolie, glucosemonohydrat, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinhydrochlorid, magnesiumsulfatheptahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin, zinksulfat heptahydrat - infusionsvæske, emulsion
finomel perifer infusionsvæske, emulsion
baxter a/s - alanin, arginin, calciumchloriddihydrat, fiskeolie, glucosemonohydrat, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinhydrochlorid, magnesiumsulfatheptahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin, zinksulfat heptahydrat - infusionsvæske, emulsion
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidæmi - lipid modificerende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.